Contact
Please use this form to send email to PR contact of this press release:
Orphan designation: Zanidatamab, Treatment of gastric cancer, 13/11/2020, Positive
TO:
Please use this form to send email to PR contact of this press release:
Orphan designation: Zanidatamab, Treatment of gastric cancer, 13/11/2020, Positive
TO: